The Role of Annexin II in Angiogenesis and Tumor Progression: A Potential Therapeutic Target

E-ISSN： 1873-4286|13|35|3568-3575

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.35, 2007-12, pp. : 3568-3575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor Angiogenesis: A Potential Target In Cancer Control by Phytochemicals

Current Cancer Drug Targets, Vol. 3, Iss. 3, 2003-06 ,pp. : 205-217

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-integrins as a potential therapeutic target in angiogenesis

By Mousa S.A.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. : 1237-1248

Informa Healthcare

Access to resources Recommend Favorite

SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target

Current Pharmaceutical Design, Vol. 20, Iss. 39, 2014-12 ,pp. : 6182-6190

Bentham Science Publishers

Access to resources Recommend Favorite

Integrin v&bgr;3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis

Current Drug Targets, Vol. 4, Iss. 2, 2003-02 ,pp. : 123-131

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis as a therapeutic target in cancer

By Kumaran Gireesh Clamp Andrew R Jayson Gordon C

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 455-458

Royal College Of Physicians

Access to resources Recommend Favorite